deoxynivalenol has been researched along with Carcinoma, Epidermoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Del Favero, G; Gerner, C; Hohenbichler, J; Janker, L; Kiss, E; Marko, D; Neuditschko, B; Woelflingseder, L | 1 |
| Del Favero, G; Gallina, P; Gerner, C; Janker, L; Marko, D; Neuditschko, B; Sbaizero, O; Seriani, S; Woelflingseder, L | 1 |
| Eppley, RM; Hines, FA; Lambert, LA | 1 |
3 other study(ies) available for deoxynivalenol and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Exploring the dermotoxicity of the mycotoxin deoxynivalenol: combined morphologic and proteomic profiling of human epidermal cells reveals alteration of lipid biosynthesis machinery and membrane structural integrity relevant for skin barrier function.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cells, Cultured; Dose-Response Relationship, Drug; Epidermal Cells; Fusarium; Humans; Keratinocytes; Lipids; Mitochondria; Proteomics; Secondary Metabolism; Trichothecenes | 2021 |
Deoxynivalenol induces structural alterations in epidermoid carcinoma cells A431 and impairs the response to biomechanical stimulation.
Topics: Biomechanical Phenomena; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Shape; Cell Survival; Cytoskeleton; Humans; Lysosomes; Proteome; Trichothecenes; Tubulin | 2018 |
Lack of initiation and promotion potential of deoxynivalenol for skin tumorigenesis in Sencar mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Body Weight; Carcinoma, Squamous Cell; Data Interpretation, Statistical; Female; Hyperplasia; Mice; Organ Size; Papilloma; Random Allocation; Skin; Skin Neoplasms; Spleen; Tetradecanoylphorbol Acetate; Trichothecenes | 1995 |